Haemonetics Corp.
(NYSE : HAE)

( )
HAE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.34%465.101.0%$731.52m
ABTAbbott Laboratories -0.02%118.290.8%$614.91m
MDTMedtronic Plc -0.10%125.140.6%$528.59m
DHRDanaher Corp. 0.03%253.650.7%$510.15m
ISRGIntuitive Surgical, Inc. -0.13%832.342.3%$508.48m
BDXBecton, Dickinson & Co. 0.04%242.481.0%$368.51m
BSXBoston Scientific Corp. -0.02%41.541.0%$364.50m
ALGNAlign Technology, Inc. 0.00%569.046.3%$329.80m
DXCMDexCom, Inc. 0.00%333.257.8%$288.03m
SYKStryker Corp. 0.13%253.291.3%$274.34m
EWEdwards Lifesciences Corp. 0.06%89.540.4%$251.67m
BAXBaxter International, Inc. -0.05%83.821.8%$206.38m
AAgilent Technologies, Inc. 0.11%131.301.6%$196.63m
IDXXIDEXX Laboratories, Inc. 0.00%530.073.8%$189.57m
ZBHZimmer Biomet Holdings, Inc. -0.08%167.131.7%$174.37m

Company Profile

Haemonetics Corp. is a global healthcare company, which engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.